Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riku Elovainio

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Health Economics, Policy, and Law|March 24, 2017
Raising more domestic money for health: prospects for low- and middle-income countriesRiku Elovainio, David B Evans
Tropical Medicine & International Health : TM & IH|October 20, 2011
Utilization and expenditure at public and private facilities in 39 low-income countriesPriyanka Saksena, Ke Xu, Riku Elovainio, et al.
BMC International Health and Human Rights|November 10, 2012
Moving from ideas to action - developing health financing systems towards universal coverage in AfricaLaurent Musango, Juliet Nabyonga Orem, Riku Elovainio, et al.
Frontiers in Public Health|February 2, 2023
Assessment of blood cultures and antibiotic susceptibility testing for bacterial sepsis diagnosis and utilization of results by clinicians in Benin: A qualitative studyBrice Boris Legba, Victorien Dougnon, Hornel Koudokpon, et al.
Health Economics, Policy, and Law|March 24, 2017
Towards a coherent global framework for health financing: recommendations and recent developmentsTrygve Ottersen, Riku Elovainio, David B Evans, et al.
Trials|November 16, 2023
Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in MaliJuho Luoma, Laura Adubra, Dagmar Alber, et al.
Trials|January 3, 2023
Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trialLaura Adubra, Dagmar Alber, Per Ashorn, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Health Economics, Policy, and Law|March 24, 2017
Raising more domestic money for health: prospects for low- and middle-income countriesRiku Elovainio, David B Evans
Tropical Medicine & International Health : TM & IH|October 20, 2011
Utilization and expenditure at public and private facilities in 39 low-income countriesPriyanka Saksena, Ke Xu, Riku Elovainio, et al.
BMC International Health and Human Rights|November 10, 2012
Moving from ideas to action - developing health financing systems towards universal coverage in AfricaLaurent Musango, Juliet Nabyonga Orem, Riku Elovainio, et al.
Frontiers in Public Health|February 2, 2023
Assessment of blood cultures and antibiotic susceptibility testing for bacterial sepsis diagnosis and utilization of results by clinicians in Benin: A qualitative studyBrice Boris Legba, Victorien Dougnon, Hornel Koudokpon, et al.
Health Economics, Policy, and Law|March 24, 2017
Towards a coherent global framework for health financing: recommendations and recent developmentsTrygve Ottersen, Riku Elovainio, David B Evans, et al.
Trials|November 16, 2023
Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in MaliJuho Luoma, Laura Adubra, Dagmar Alber, et al.
Trials|January 3, 2023
Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trialLaura Adubra, Dagmar Alber, Per Ashorn, et al.
Pageof 1